| Dr Michael D Gagliardi, MD | |
|
540 Waverly Place, Suite 200, Cary, NC 27511-5562 | |
| (919) 954-4159 | |
| Not Available |
| Full Name | Dr Michael D Gagliardi |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 32 Years |
| Location | 540 Waverly Place, Cary, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083770044 | NPI | - | NPPES |
| 891247F | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2000-00056 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Duke University Affiliated Physicians Inc | 3779489588 | 459 |
News Archive
Dr. Kyran Quinlan and colleagues at Rush issue an urgent call for prevention strategies for sleep-related infant deaths in his viewpoint, "Protecting Infants From Sleep-Related Deaths" published in the June 18 online issue of JAMA Pediatrics.
The NHS would have a tough year ahead said the NHS Confederation suggesting 2011 could end up being the "toughest year" in the NHS' 62-year history. The major issues would be the structural reforms from health secretary Andrew Lansley, the difficulty of finding £20 billion of efficiency savings and the uncertainty created by debate over a major piece of healthcare legislation would all contribute to a tough year.
Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, presented the results of its recently completed Phase IIb trial. The multicenter, placebo-controlled, randomized, double-blind study conducted in 29 patients with Type II diabetes assessed the safety of ORMD-0801 in patients with Type II diabetes.
A nationwide US study has found that early exposure to ambient air toxics does not associate with the prevalence of asthma in young children.
› Verified 2 days ago
| Entity Name | Duke University Affiliated Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316975972 PECOS PAC ID: 3779489588 Enrollment ID: O20031211000642 |
News Archive
Dr. Kyran Quinlan and colleagues at Rush issue an urgent call for prevention strategies for sleep-related infant deaths in his viewpoint, "Protecting Infants From Sleep-Related Deaths" published in the June 18 online issue of JAMA Pediatrics.
The NHS would have a tough year ahead said the NHS Confederation suggesting 2011 could end up being the "toughest year" in the NHS' 62-year history. The major issues would be the structural reforms from health secretary Andrew Lansley, the difficulty of finding £20 billion of efficiency savings and the uncertainty created by debate over a major piece of healthcare legislation would all contribute to a tough year.
Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, presented the results of its recently completed Phase IIb trial. The multicenter, placebo-controlled, randomized, double-blind study conducted in 29 patients with Type II diabetes assessed the safety of ORMD-0801 in patients with Type II diabetes.
A nationwide US study has found that early exposure to ambient air toxics does not associate with the prevalence of asthma in young children.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael D Gagliardi, MD Po Box 751274, Charlotte, NC 28275-1274 Ph: () - | Dr Michael D Gagliardi, MD 540 Waverly Place, Suite 200, Cary, NC 27511-5562 Ph: (919) 954-4159 |
News Archive
Dr. Kyran Quinlan and colleagues at Rush issue an urgent call for prevention strategies for sleep-related infant deaths in his viewpoint, "Protecting Infants From Sleep-Related Deaths" published in the June 18 online issue of JAMA Pediatrics.
The NHS would have a tough year ahead said the NHS Confederation suggesting 2011 could end up being the "toughest year" in the NHS' 62-year history. The major issues would be the structural reforms from health secretary Andrew Lansley, the difficulty of finding £20 billion of efficiency savings and the uncertainty created by debate over a major piece of healthcare legislation would all contribute to a tough year.
Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, presented the results of its recently completed Phase IIb trial. The multicenter, placebo-controlled, randomized, double-blind study conducted in 29 patients with Type II diabetes assessed the safety of ORMD-0801 in patients with Type II diabetes.
A nationwide US study has found that early exposure to ambient air toxics does not associate with the prevalence of asthma in young children.
› Verified 2 days ago
Dr. Lucia Fernanda Reyes, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 Ashville Ave Ste 10, Cary, NC 27518 Phone: 919-350-7231 | |
Dr. Fred Scott Rabon, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Sas Campus Dr, Cary, NC 27513 Phone: 919-531-9004 Fax: 919-654-3800 | |
Dr. Mrinalini Sujala Kodumagulla, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1831 Lake Pine Dr Ste 200, Cary, NC 27511 Phone: 919-380-1849 Fax: 919-380-1851 | |
Daniel C Richard, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 600 New Waverly Pl, Ste 203, Cary, NC 27518 Phone: 919-859-5650 Fax: 919-859-5695 | |
Mrs. Claudia Lucia Gomez, FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 540 New Waverly Pl Ste 200, Cary, NC 27518 Phone: 919-954-4159 Fax: 919-954-4445 | |
Essie Lee, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1515 Sw Cary Pkwy, Cary, NC 27511 Phone: 919-387-3180 |